Accueil/Actions/CYBN

CYBN

USD

Cybin Inc. Common Shares

$6.170-0.410 (-6.231%)

Prix en Temps Réel

Healthcare

Biotechnologie

Canada

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché

Fondamentaux de l'Entreprise

Statistiques de Trading

Métriques de Marché

Ouverture

$6.580

Haut

$6.830

Bas

$6.170

Volume

1.59M

Fondamentaux de l'Entreprise

Capitalisation Boursière

332.8M

Industrie

Biotechnologie

Pays

Canada

Statistiques de Trading

Volume Moyen

0.74M

Bourse

ASE

Devise

USD

Intervalle sur 52 Semaines

Bas $4.81Actuel $6.170Haut $13.88

Actualités Connexes

3 nov. 2025 · 12:30

BusinessWire

Cybin to Participate at the 2025 Milken Institute Future of Health Summit

- Chief Medical Officer Amir Inamdar to participate in a panel on November 5, 2025 - Cybin Inc. (NYSE:CYBN) (Cboe CA:CYBN) ("Cybin" or the "Company"), a breakthrough Phase 3 clinical stage neuropsychiatry company

Cybin to Participate at the 2025 Milken Institute Future of Health Summit

31 oct. 2025 · 20:19

BusinessWire

Cybin Announces Closing of $175 Million Registered Direct Offering

Cybin Inc. (Cboe CA: CYBN) (NYSE:CYBN) ("Cybin" or the "Company"), a breakthrough Phase 3 clinical stage neuropsychiatry company committed to revolutionizing mental healthcare through proprietary drug discovery